PHGE — BiomX Inc.
—
NYSE ·
Health Care ·
Biotechnology ·
CIK 1739174 ·
Last close
$0.13
Market Cap
$3.56M
52W High
$1.89
52W Low
$0.12
ADV30
1,549,269
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -1,296,000 | -19,140,000 | 3,251,000 | 1,168,000 | 4,132,000 |
| Dec 2025 | 0 | — | -7,195,000 | -13,337,000 | 5,783,000 | 4,360,000 | 7,085,000 |
| Sep 2025 | 0 | — | -8,536,000 | -9,166,000 | 26,168,000 | 6,923,000 | 15,682,000 |
| Jun 2025 | 0 | — | -7,433,000 | -6,037,000 | 38,050,000 | 14,046,000 | 18,890,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-23,092,000
Investing CF
$-939,000
Financing CF
$3,899,000
CapEx
$-11,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-22.77
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-236,036,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-48,188,000
Pretax Income TTM
$-47,674,000
Interest Exp TTM
$-514,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$332,000
EBITDA
$-20,042,000
Free Cash Flow
$-4,043,625
Enterprise Value
$17,737,532
Total Cash
$572,000
Total Debt
$1,365,000
Shares Out
26,559,607
Trailing EPS
$-23.30
Book Value
$-12.50
ROE
-247.3%
ROA
-42.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -30,920,000 | -36,199,000 | 5,783,000 | 7,085,000 | — | -26,390,000 |
| Dec 2024 | 0 | -35,551,000 | -17,727,000 | 43,233,000 | 19,085,000 | — | -36,979,000 |
| Dec 2023 | 0 | -25,348,000 | -26,169,000 | 25,029,000 | 21,948,000 | — | -21,286,000 |
| Dec 2022 | 0 | -27,219,000 | -28,317,000 | 45,531,000 | 24,492,000 | — | -29,092,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-6.01
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CLDI | Calidi Biotherapeutics, Inc. | $3.57M | $1.38 | — |
| CRIS | CURIS INC | $3.83M | $1.58 | — |
| VIVS | VivoSim Labs, INC. | $3.91M | $0.29 | — |
| BCAB | BioAtla, Inc. | $5.46M | $3.28 | — |
| PMCB | PharmaCyte Biotech, Inc. | $5.64M | $0.52 | — |
News headlines (Yahoo Finance, 1h cache)
BiomX Subsidiary Zorronet Receives Approximately $300,000 Purchase Order to Build Unified Operational Environment at Defense Technology Test and Evaluation Site
2026-08-14 12:32 · Yahoo
BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems
2026-08-05 12:45 · Yahoo
BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms
2026-07-28 13:15 · Yahoo
BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
2026-07-24 11:45 · Yahoo
BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities
2026-07-10 11:25 · Yahoo
BiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways Agreement
2026-07-06 12:32 · Yahoo
BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026
2026-06-24 12:38 · Yahoo
BiomX Provides Update on Defense Technology Portfolio and Growth Strategy
2026-06-18 13:15 · Yahoo
BiomX Announces NYSE American Acceptance of Plan to Regain Compliance
2026-06-12 13:00 · Yahoo
BiomX: Zorronet’s AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events
2026-06-11 13:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.